Phase II Study of Sitravatinib in Combination with Tislelizumab in Patients with Advanced Biliary Tract Cancer Who Have Failed to At Least 1 Prior Systemic Treatment.

Category Primary study
Registry of TrialsKorean Clinical Trials Database
Year 2020
This article has no abstract
Epistemonikos ID: a59aa9a32def21d555f94ce16ec54deb56b820d6
First added on: Apr 11, 2025